Food & Drug Administration
FDA Approves Controversial Alzheimer's Drug
Jul 12, 2021 at 03:30 pm by Staff
On June 7, the Food & Drug Administration approved Aduhelm (aducanumab) to treat Alzheimer's patients, making it the first new drug approval for a disease impacting more t.... Read More
Taking the Initiative on Kidney Care
Mar 09, 2020 at 11:41 am by Staff
KHI, KidneyX, New Executive Order Create Collaborative Focus
Recent data from the Centers for Disease Control and Prevention shows more than 35 million Americans are affected.... Read More
President Signs FDA User Fee Legislation
Aug 25, 2017 at 12:02 am by Staff
On Aug. 18, President Donald Trump signed bipartisan legislation authored by Senate health committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.... Read More
FDA Approves Drug to Treat Duchenne Muscular Dystrophy
Feb 10, 2017 at 08:10 am by Staff
On Feb. 9, the U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dyst.... Read More